Siirry transaktioihin
Pääomasijoittaminen | Terveydenhuolto

Trust Chemists and Druggists Private Limited has raised equity

Trust Chemists and Druggists Private Limited has successfully completed an equity raise.

Founded in 2003, Trust Chemists and Druggists operates one of the largest hospital pharmacy chains in India. Specializing in managing in-hospital pharmacies, the company operates 47 in-hospital stores and 14 standalone stores across Karnataka, Tamil Nadu and Andhra Pradesh. It offers a one-stop shop for all medicines and wellness needs.

Oaklins’ team in India provided strategic and financial advisory services throughout this transaction. The team onboarded an investor, a family office, adding strategic value and contributing to financial growth. This investor acquired a 26% fully diluted stake in the investee.

Ota yhteyttä transaktiotiimiin

Vikas Dawra

Managing Partner
Mumbai, Intia
Oaklins VantagePoint

Deepak Tulsian

Associate Director
Mumbai, Intia
Oaklins VantagePoint

Transaktiot

Afric Phar has been acquired by Pharma Capital
Terveydenhuolto

Afric Phar has been acquired by Pharma Capital

Pharma Capital S.A. has acquired a significant stake in the Moroccan pharmaceutical group Afric Phar, which includes leading companies Afric Phar, Pharmis and Partner Lab, from the Chaoui family, in one of the largest transactions in the Moroccan pharmaceutical sector.

Lue lisää
Den Berk Délice accelerates growth through strategic partnership
Pääomasijoittaminen | Maatalous

Den Berk Délice accelerates growth through strategic partnership

Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.

Lue lisää
Xiel Limited has been acquired by MIS Healthcare
Pääomasijoittaminen | Terveydenhuolto

Xiel Limited has been acquired by MIS Healthcare

MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.

Lue lisää